[1]Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998.Thorax,1998,53(7):536-548.[2]Snider DE Jr, Cohn DL, Davidson PT, et al. Standard therapy for tuberculosis 1985. Chest, 1985,87(2 Suppl):117S-124S.[3]Horsburgh CR Jr, Feldman S, Ridzon R,et al. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis, 2000,31(3):633-639.[4]Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med,2003,167(4):603-622.[5]Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ,1994,150(8):1233-1239.[6]张秋滨,闫红,刘波. 皮质激素在结核病治疗中的合理应用. 黑龙江医学,2005,29(1):30-31.[7]马玙,朱莉贞,潘毓萱. 结核病. 北京:人民卫生出版社,2006:254-262.[8]Pardridge WM. Drug targeting to the brain. Pharm Res, 2007,24(9):1733-1744.[9]World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003. Geneva: WHO,2003.[10]Donald PR, Schoeman JF, Van Zyl LE, et al. Intensive short course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis,1998, 2(9):704-711.[11]Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect, 2009, 59(3):167-187.[12]彭卫生,王英年,肖成志. 新编结核病学. 2版.北京:中国医药科技出版社,2003:34-247.[13]Dutt AK, Stead WW. Treatment of extrapulmonary tuberculosis. Semin Respir Infect, 1989,4(3):225-231.[14]余秉真,闫世明,邹志艳,等. 205例成人结核性脑膜炎治疗探讨. 中华结核和呼吸杂志,1992,15(2):79-80.[15]严碧涯,端木宏谨.结核病学.北京:北京出版社,2003.[16]邹级谦.复治肺结核标准化疗方案之我见.中华结核和呼吸杂志,2009,32(8):564-565.[17]杜建,徐彩红,李琦,等.不同类型治疗方案治疗耐多药结核病效果文献分析.中国防痨杂志,2010,32(8):421-426.[18]中国防痨协会.耐药结核病化学治疗指南(2009).中国防痨杂志,2010,32(4):181-198.[19]Alffenaar JW, van Altena R, Bokkerink HJ, et al. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis, 2009,49(7):1080-1082.[20]Katiyar SK, Bihari S, Prakash S, et al. A randomized controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis,2008,12(2):139-145.[21]Falzon D,Jaramillo E,Schünemann HJ,et al.WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J,2011,38(3):516-528.[22]屠德华. 从指南的制定谈规范耐多药结核病的化学治疗.中华结核和呼吸杂志,2010,33(7):483484.[23]韩利军,闫世明,赵云虹,等. 20例成人耐药结核性脑膜炎临床观察. 中国防痨杂志,2010,32(4):224-226.[24]牟君,霍康,谢鹏.皮质激素辅助治疗结核性脑膜炎的研究现状.中国防痨杂志,2008,30(4):352-354.[25]Evans DJ.The use of adjunctive corticosteroids in the treatment of pericardial, pleural and meningeal tuberculosis:do they improve outcome? Respir Med,2008,102(6):793-800.[26]Simmons CP,Thwaites GE,Quyen NT,et al.The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or immune responses.J Immunol,2005, 175(1):579-590.[27]王焱烽,陈冰,姚茂元. 糖皮质激素冲击治疗Ⅲ期结核性脑膜炎疗效观察. 临床医学,2009,29(12):21-22.[28]Fitch MT, van de Beek D. Drug Insight:steroids in CNS infectious diseases——new indications for an old therapy. Nat Clin Pract Neurol, 2008,4(2): 97-104.[29]闫世明,邹志艳,安龙浩,等. 大剂量短程地塞米松治疗结核性脑膜炎临床探讨. 中国防痨杂志,1994,16(4):155-157.[30]董庆林,井西伟,岳红,等.糖皮质激素辅助治疗成人结核性脑膜炎的疗效观察.临床神经病学杂志,2004,17(1):42-43.[31]McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med, 2008, 168(10): 1034-1046.[32]Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev, 2008,(1):CD002244.[33]闫世明,孙秀娟,邹志艳,等. 不同剂量地塞米松治疗结核性脑膜炎的对比观察. 中华结核和呼吸杂志,1995,18(4):236.[34]闫世明,潘桂芬,杨家道. 结核性脑膜炎患者甲状腺肾上腺皮质性腺激素水平的研究. 中华结核和呼吸杂志,1998,21(7):433.[35]邵平波,汪思敏,佟士秀,等. 成人结核性脑膜炎445例临床分析. 中华结核和呼吸系统疾病杂志,1980,3:131. |